All Cancer Microbiology articles – Page 17
-
NewsBat immune genes protect against COVID and cancer
Bats have acquired remarkable traits throughout their evolution. They’re the only mammals that can fly, and they live much longer than other animals their size. But perhaps most impressive is their robust immune system. It protects bats from viruses that wreak havoc in humans, like COVID-19 or Ebola, and also ...
-
NewsEngineered bacteria paint targets on tumors for cancer-killing T cells to see
Columbia engineers are the first to program bacteria to act as beacons that guide the activity of engineered T cells. This work is also the first to design interactions between these two “living” medicines to enable targeting of a range of solid tumor.
-
NewsGut microbiome variations could predict colorectal cancer risk
New research has identified significant variations in the gut microbiome of individuals who developed pre-cancerous colonic lesions, suggesting a potential connection between gut bacteria and the onset of colorectal lesions and cancers.
-
NewsEngineered bacteria guide CAR-T cells to poorly infiltrated solid tumors
A new probiotic-guided chimeric antigen receptor (CAR)-T platform uses engineered bacteria to infiltrate and produce synthetic antigen targets, enabling CAR-T cells to find, identify, and destroy tumor cells in situ, according to a new study.
-
NewsMicrobiome molecule may hamper immune cells’ cancer-fighting abilities
An important group of immune cells in the large bowel - gamma delta T cells - are crucial to preventing bowel cancer, but a molecule linked to gut microbiome diversity may suppress their immune response.
-
NewsOral lipid nanoparticle drug can prevent development of colitis-associated cancer
An oral lipid nanoparticle drug prevents tumor development in mice, suggesting this is a promising drug formulation for preventing colitis-associated cancer, according to a study led by researchers in the Institute for Biomedical Sciences at Georgia State University. The findings published in the journal Pharmaceutics report the ...
-
NewsISM hosting symposium on probiotics and microbiota supplements applications
The International Society of Microbiota has announced an upcoming symposium dedicated to clinicians on probiotics and microbiota supplements.
-
NewsResearchers tweak photosynthetic bacteria to combat tumours
Scientists succeed in enhancing the anticancer efficacies of purple photosynthetic bacteria by tagging them with bioactive molecules and polyethylene glycol derivatives.
-
NewsHigh-fat diets alter gut bacteria, boosting colorectal cancer risk in mice
Scientists have pinpointed specific microbes and bile acids that become more prevalent in the guts of mice fed high-fat diets.
-
NewsPurecap technique opens doors to more effective mRNA vaccines
Researchers have developed a method to produce highly active mRNA vaccines at high purity using a unique cap to easily separate the desired capped mRNA.
-
NewsNanoparticle may improve mRNA cancer vaccines
Tests in mice with melanoma and colon cancer show the tiny particle creates an ‘army’ of immune cells that carry vaccine’s instructions, say the researchers.
-
NewsCombining virus therapy with radiation to fight brain cancer works better than either treatment alone
Combining a cancer-targeting virus with radiation to treat brain cancer in mice was more effective than either therapy on its own, according to new research, providing hope for new treatments that combine immunotherapy with traditional surgery, chemotherapy or radiation.
-
NewsVirus aids breakthrough in glioblastoma treatment
Scientists have reported a breakthrough in glioblastoma treatment following a recent clinical trial that used a modified cold virus injected directly into the tumor.
-
NewsGut microbiome changes linked to precancerous colon polyps
A new study has linked certain types of gut bacteria to the development of precancerous colon polyps.
-
NewsEngineered virus with immunotherapy safe and improves cancer outcomes
A new study validates the safety of a combination approach using an engineered virus and immunotherapy to target an aggressive brain cancer, and offers promise to adapt treatment strategies.
-
NewsIntestinal bacteria influence the growth of fungi
The bacteria present in the intestine provide information about the quantities of fungi of the potentially disease-causing Candida genus - among them, surprisingly, are lactic acid bacteria that are known for their protective effect against fungal infections.
-
NewsCRISPR-based drug candidate targets the microbiome
Scientists have engineered the first published CRISPR-based candidate for a drug - a combination of phages - that targets E. coli directly and leaves the microbiome intact.
-
NewsTumour bacteria can trigger anticancer response
A novel approach to treating cancer uses bacteria that naturally reside within tumours to trigger a powerful anticancer immune response.
-
NewsAntibacterial treatment solves radiotherapy skin problem
A new study shows that a low-cost antibacterial regimen can prevent acute radiation dermatitis.
-
NewsGene scissors used successfully in the laboratory against HIV-related virus
Researchers have provided initial proof of concept for a potential therapeutic approach targeting HTLV-1, a retrovirus that triggers aggressive forms of leukemia or an incurable spinal cord disease that leads to paralysis.